4h-1-benzopyran-4-one derivatives, process for their preparation and their use as medicaments
Abstract
Vorliegende Erfindung betrifft neue 4H-1-Benzopyran-4- on-derivate, Verfahren zu deren Herstellung sowie deren Verwendung als Antiphlogistika, Analgetika, Immunsuppressiva und Antiallergika. Insbesondere betrifft vorliegende Erfindung neue Verbindungen der Formel I, worin R, für Wasserstoff, Alkyl mit 1 bis 6 Kohlenstoffatomen, Aryl-C1-C4-alkyl, substituiertes C1-C8-Alkyl, C3-C8-Cycloalkyl, C3-C6-Cycloalklyl-C1-C4-alkyl, C2-C6-Alkenyl, C2-C6-Alkinyl, Aryl, Carboxyl oder eine Aldehyd- oder COO-C1-C4-Alkylgruppe, R2 für Wasserstoff, Alkyl mit 1 bis 6 Kohlenstoffatomen, Nitro, Amino, Aryl, Carboxyl, Di-C1-C4-alkylamino, oder ein Halogen, R3 für C1-C4-Alkyl, substituiertes C1-C4-Alkyl, Hydroxyl, C1-C4-Alkoxy,Aryl-C1-C4-alkyl, Nitro, Amino, eine C1-C4-Alkyl- oder di-C1-C4-alkylaminogruppe oder Halogen, R4 für Wasserstoff, Hydroxyl, C1-C4-Alkoxy, C1-C4-Alkanoyloxy, C1-C4-Alkoxycarbonyl, Aryloxy, Amino oder eine C1-C4-Alkyl- oder Di-C1-C4-Alkylaminogruppe, n für die ganze Zahl 0, 1 oder 2 und R5 für Wasserstoff, C1-C6-Alkyl, substituiertes C1-C6-Alkyl,Aryl-C1-C4-alkyl, C3-C6-Cycloalkyl, C3-C6-Cycloalkyl-C1-C4-alkyl, C1-C4-Alkanoyl oder Aroyl, wobei die Arylgruppe gegebenenfalls einfach oder mehrfach substituiertes Phenyl ist, stehen, m eine ganze Zahl zwischen 0 und 3 und n eine ganze Zahl zwischen 0 und 2 bedeuten, sowie deren pharmakologisch unbedenkliche Säuradditionssalze.

Term
Term ended
Projected expiry passed 8 April 2007, 19.5 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
1 sheet
Sheet 1
Every citation, both waysCites: the store holds 4 of 5
| Document | Relation | Office | Category | Cited during |
|---|---|---|---|---|
| EP0000377A1 | Cites | European Patent Office (EPO) | Y | Search report |
| EP0137193A2 | Cites | European Patent Office (EPO) | XD | Search report |
| DE1802961B2 | Cites | Germany | Y | Search report |
| GB2101115A | Cites | United Kingdom | Y | Search report |
| TETRAHEDRON LETTERS, Band 79, Nr. 8, 1979, Seiten 721-724, Pergamon Press Ltd., GB; A.D. HARMON et al.: "The structure of rohitukine, the main alkoloid of amoora rohituka (Syn. Aphanamixis polystachya) (Meliaceae)" | Non-patent | – | – | Search report |
31 members in 16 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 3612337 | Germany | A | |
| 3612337 | Germany | A | |
| 3612337 | Germany | – | |
| 3612337 | – | – | – |
| DE19863612337 | – | – | – |
Members31
| Document | Office | Kind | |
|---|---|---|---|
| DK185287D0 | Denmark | D0 | |
| PT84654A | Portugal | A | |
| IE870941L | Ireland | L | |
| DK185287A | Denmark | A | |
| EP0241003A2 | European Patent Office (EPO) | A2 | |
| AU7139787A | Australia | A | |
| DE3612337A1 | Germany | A1 | |
| JPS62242680A | Japan | A | |
| IL82149A0 | Israel | A0 | |
| IL82149D0 | Israel | D0 | |
| ZA872555B | South Africa | B | |
| KR870010045A | Republic of Korea | A | |
| EP0241003A3This record | European Patent Office (EPO) | A3 | |
| IN164232B | India | B | |
| ATA260587A | Austria | A | |
| PT84654B | Portugal | B | |
| AT389875B | Austria | B | |
| US4900727A | United States of America | A | |
| AU602891B2 | Australia | B2 | |
| EP0241003B1 | European Patent Office (EPO) | B1 | |
| AT95519T | Austria | T | |
| ATE95519T1 | Austria | T1 | |
| DE3787661D1 | Germany | D1 | |
| IL82149A | Israel | A | |
| CA1332238C | Canada | C | |
| JPH0686446B2 | Japan | B2 | |
| ES2060582T3 | Spain | T3 | |
| IE62244B1 | Ireland | B1 | |
| DK169760B1 | Denmark | B1 | |
| KR950009861B1 | Republic of Korea | B1 | |
| HK1006021A1 | Hong Kong, China | A1 |
43 legal events, as 5 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Be: patent expiredExpiredBE20 | BE20 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Announcement of lapse in spainLapsedFD2A | FD2A | ES | |
| Se: european patent has lapsedLapsedEUG | EUG | EP | |
| Nl: ceased due to reaching the maximum lifetime of a patentCeasedNLV7 | NLV7 | EP | |
| Patent expired after termination of 20 yearsExpiredPE20 | PE20 | GB | |
| Patent ceasedCeasedPL | PL | CH | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| European patent in force as of 2002-01-01IF02 | IF02 | GB | |
| Se: european patent in force in swedenEAL | EAL | EP | |
| Definitive protectionFG2A | FG2A | ES | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Lu: last paid annual feeEPTA | EPTA | EP | |
| Validation in greece3010231FG4A | FG4A | GR | |
| Fr: translation filedET | ET | EP | |
| Gb: translation of ep patent filed (gb section 77(6)(a)/1977)GBT | GBT | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| Corresponds to:REF | REF | EP | |
| Designated contracting statesAK | AK | EP | |
| Corresponds to:REF | REF | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 0241003
- Publication, DOCDB
- 0241003
- Publication, EPODOC
- EP0241003
- Application
- 87105180
- Application, DOCDB
- 87105180
- Application, EPODOC
- EP19870105180
Titles3
- English
- 4H-1-benzopyran-4-one derivatives, process for their preparation and their use as medicaments
- French
- Dérivés de 4H-1-benzopyran-4-one, procédé pour leur préparation et leur utilisation comme médicaments
- German
- 4H-1-Benzopyran-4-on-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
Classification
- CPC, 6
- C07D405/04
- C07D211/42
- C07D405/14
- A61P25/04
- A61P37/06
- A61P37/08
- IPC, 13
- A61K31 44
- A61K31 443
- A61P25 04
- A61P37 06
- A61P37 08
- C07D211 42
- C07D211 70
- A61K31 445
- C07D211 74
- C07D405 04
- C07D405 12
- C07D405 14
- C07F9 553
Designated states1
- Contracting states, 1
- Sweden